Dr. Shahzad Raza, MD
Claim this profileSaint Luke's Hospital of Kansas City
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
3 reported clinical trials
6 drugs studied
Area of expertise
1Lung Cancer
Stage I
Stage II
ALK positive
2Non-Small Cell Lung Cancer
Stage I
Stage II
ALK positive
Affiliated Hospitals
Clinical Trials Shahzad Raza, MD is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Lenalidomide + Dexamethasone +/- Daratumumab
for Multiple Myeloma
This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread. Giving lenalidomide and dexamethasone with daratumumab may work better in treating patients with smoldering myeloma.
Recruiting2 awards Phase 312 criteria
More about Shahzad Raza, MD
Clinical Trial Related9 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Shahzad Raza, MD has experience with
- Crizotinib
- Dexamethasone
- Daratumumab
- Lenalidomide
- Berubicin
- Lomustine
Breakdown of trials Shahzad Raza, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
ALK Gene Rearrangement
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shahzad Raza, MD specialize in?
Shahzad Raza, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage I patients, or patients who are Stage II.
Is Shahzad Raza, MD currently recruiting for clinical trials?
Yes, Shahzad Raza, MD is currently recruiting for 2 clinical trials in Kansas City Missouri. If you're interested in participating, you should apply.
Are there any treatments that Shahzad Raza, MD has studied deeply?
Yes, Shahzad Raza, MD has studied treatments such as Crizotinib, Dexamethasone, Daratumumab.
What is the best way to schedule an appointment with Shahzad Raza, MD?
Apply for one of the trials that Shahzad Raza, MD is conducting.
What is the office address of Shahzad Raza, MD?
The office of Shahzad Raza, MD is located at: Saint Luke's Hospital of Kansas City, Kansas City, Missouri 64111 United States. This is the address for their practice at the Saint Luke's Hospital of Kansas City.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.